CINECA IRIS Institutional Research Information System

FORNAI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.466
AS - Asia 5.929
EU - Europa 5.913
SA - Sud America 940
AF - Africa 346
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 5
Totale 26.624
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.090
IT - Italia 2.433
CN - Cina 1.794
SG - Singapore 1.728
HK - Hong Kong 1.074
SE - Svezia 835
BR - Brasile 797
DE - Germania 567
BG - Bulgaria 430
VN - Vietnam 369
GB - Regno Unito 348
CA - Canada 270
TR - Turchia 267
RU - Federazione Russa 262
FI - Finlandia 225
AT - Austria 206
IN - India 153
UA - Ucraina 149
CI - Costa d'Avorio 148
KR - Corea 123
FR - Francia 112
JP - Giappone 83
NL - Olanda 78
PL - Polonia 65
MX - Messico 61
AR - Argentina 60
CH - Svizzera 50
SN - Senegal 47
BD - Bangladesh 44
BE - Belgio 44
PK - Pakistan 40
IQ - Iraq 36
NG - Nigeria 34
UZ - Uzbekistan 31
ZA - Sudafrica 30
IR - Iran 27
ID - Indonesia 24
ES - Italia 22
VE - Venezuela 21
MA - Marocco 20
EC - Ecuador 19
AU - Australia 18
SA - Arabia Saudita 18
EG - Egitto 15
CZ - Repubblica Ceca 14
LT - Lituania 13
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 12
CO - Colombia 12
PH - Filippine 12
PY - Paraguay 12
KE - Kenya 11
TW - Taiwan 11
MY - Malesia 10
CL - Cile 9
DZ - Algeria 9
IE - Irlanda 9
PT - Portogallo 9
JM - Giamaica 8
PA - Panama 8
TN - Tunisia 8
BJ - Benin 7
HN - Honduras 7
JO - Giordania 7
NO - Norvegia 7
OM - Oman 7
AL - Albania 6
HU - Ungheria 6
KG - Kirghizistan 6
KZ - Kazakistan 6
LB - Libano 6
NZ - Nuova Zelanda 6
IL - Israele 5
TT - Trinidad e Tobago 5
DO - Repubblica Dominicana 4
GH - Ghana 4
NP - Nepal 4
PE - Perù 4
QA - Qatar 4
RO - Romania 4
UY - Uruguay 4
AO - Angola 3
BY - Bielorussia 3
DK - Danimarca 3
EU - Europa 3
GD - Grenada 3
GR - Grecia 3
LV - Lettonia 3
PS - Palestinian Territory 3
RS - Serbia 3
BN - Brunei Darussalam 2
BS - Bahamas 2
CG - Congo 2
GE - Georgia 2
GT - Guatemala 2
MK - Macedonia 2
SV - El Salvador 2
TH - Thailandia 2
TJ - Tagikistan 2
UG - Uganda 2
Totale 26.602
Salva come PNG Salva come JPEG
Città #
Ashburn 1.422
Woodbridge 1.125
Fairfield 1.106
Hong Kong 1.052
Singapore 970
Ann Arbor 959
Dallas 951
Houston 868
Chandler 821
Santa Clara 774
Milan 487
Seattle 438
Sofia 427
Wilmington 426
Shanghai 419
Beijing 391
Cambridge 387
Serra 382
New York 303
Boardman 256
Los Angeles 213
Ottawa 200
Princeton 184
Jacksonville 162
Lawrence 160
Abidjan 148
Pisa 148
Izmir 147
Vienna 146
Medford 139
Hefei 133
Florence 128
Munich 122
Dong Ket 112
Nanjing 108
Des Moines 105
Seoul 101
London 96
Rome 95
Chicago 84
Istanbul 82
Buffalo 78
Bremen 75
Redondo Beach 74
São Paulo 70
Frankfurt am Main 67
Dearborn 62
Tokyo 59
Nanchang 56
Turku 54
Lucca 53
Ho Chi Minh City 52
Council Bluffs 51
Dakar 47
Lappeenranta 45
Lancaster 44
Ogden 43
Falls Church 42
Brussels 41
Bern 40
San Diego 40
Warsaw 40
Columbus 38
Hanoi 37
Redwood City 37
The Dalles 34
Lagos 32
Pune 30
Jüchen 29
Nuremberg 29
Tashkent 28
Washington 28
Montignoso 27
Hebei 26
Marseille 26
Boulder 25
Tianjin 25
Helsinki 24
Phoenix 24
Kunming 23
Livorno 23
Atlanta 22
Fuzhou 22
Guangzhou 22
Montreal 22
Rio de Janeiro 22
Toronto 22
Brooklyn 21
Chennai 21
Naples 21
Belo Horizonte 19
Norwalk 19
Changsha 18
Kent 18
Shenzhen 18
Brasília 17
Hangzhou 17
Poplar 17
Auburn Hills 16
Düsseldorf 16
Totale 18.825
Salva come PNG Salva come JPEG
Nome #
Derivati isoindolici come attivatori di AMPK 501
Preparation of isoindoline derivatives for use as AMPK activators 314
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 283
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 254
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 246
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 237
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 230
Derivati benzofuranici come attivatori di AMPK 225
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 213
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 203
Protective effects of Saccharomyces boulardii CNCM I-745 Against Nonsteroidal anti-inflammatory drug-induced intestinal injury 201
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 200
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 196
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon 195
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 195
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 191
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 190
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 189
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 186
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 186
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 184
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 182
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 180
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 179
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 179
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 178
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 177
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 176
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 176
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 176
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 175
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 175
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 175
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 175
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 172
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 172
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 172
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 170
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 169
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 169
Efficay and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug: a review 169
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 168
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 168
Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity 165
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 165
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 165
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 165
Expression pattern of COX isoforms in experimental models of enteric and airway inflammation 164
Allopurinol adherence among patients with gout: an Italian general practice database study 164
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 164
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 163
Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases 163
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 162
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 161
Role of A2a adenosine in the regulation of colonic motility in normal human colon 161
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 161
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation 160
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies 160
Preparation of benzofuran derivatives for use as AMPK activators 159
Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease 159
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 157
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 157
Mechanisms underlying the non-anticoagulant effects of apixaban and dabigatran on the integrity of intestinal mucosa: a comparative pre-clinical study. 157
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 156
Reduced modulating actions of adenosine pathways on enteric neuromuscular activity in experimental colitis 156
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 156
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 155
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 155
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 155
Donepezil improves vascular function in a mouse model of Alzheimer's disease 155
Differential role of A1 and A2a purinergic receptors in the control of colonic neurumuscular function in the presence of experimental colitis 154
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 154
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 153
Transient acute liver failure complicating transurethral resection syndrome 152
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 151
Adenosine and inflammation: what's new on the horizon? 151
Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System? 151
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 149
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 149
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 149
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 149
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 149
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity 149
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 148
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 147
Mild hypothyroidism anticipates and accelerates age-related endothelial dysfunction in rat mesenteric small arteries: role of inducibile NO synthase 145
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 145
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 145
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 144
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity 144
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 144
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress 143
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 142
Drug-induced taste and smell alterations: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting 142
Risankizumab for the treatment of moderate to severe psoriasis 142
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 141
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 141
Quantitative and qualitative changes of colonic myenteric ganglia in patients with ulcerative colitis 140
NSAID activated gene (NAG-1) plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer repair 140
Adenosine regulation of the immune system 138
Totale 17.362
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.604
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.604
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.076 0 0 0 0 0 80 70 124 216 189 86 311
2021/20221.993 36 97 62 114 377 282 79 118 109 79 138 502
2022/20232.877 314 380 206 287 292 362 32 234 500 49 189 32
2023/20242.504 243 251 298 196 380 405 59 108 104 93 123 244
2024/20256.578 76 245 106 404 574 722 602 304 694 865 687 1.299
2025/20264.120 533 852 1.033 634 837 231 0 0 0 0 0 0
Totale 27.328